Antibiotic use and risk of gynecological cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 159, Issue 2, 2011, Pages 388-393

  Tamim, Hani M ^a,b   Musallam, Khaled M ^c   Kadri, Hanan Mf Al ^b   Boivin, Jean Franois ^d,e   Collet, Jean Paul ^f  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antibiotics; Cervical cancer; Ovarian cancer; Uterine cancer

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; MACROLIDE; PENICILLIN G; SULFONAMIDE; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANADA; CANCER RISK; CONTROLLED STUDY; DATA BASE; FEMALE; GYNECOLOGIC CANCER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OVARY CANCER; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERUS CANCER;

EID: 82255175110     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.06.018     Document Type: Article

References (22)

1. C.M. Velicer, S.R. Heckbert, J.W. Lampe, J.D. Potter, C.A. Robertson, and S.H. Taplin Antibiotic use in relation to the risk of breast cancer JAMA 291 2004 827 835
2. H.M. Tamim, J.A. Hanley, A.H. Hajeer, J.F. Boivin, and J.P. Collet Risk of breast cancer in relation to antibiotic use Pharmacoepidemiol Drug Saf 17 2008 144 150
3. R.C. Didham, D.M. Reith, D.W. McConnell, and K.S. Harrison Antibiotic exposure and breast cancer in New Zealand Breast Cancer Res Treat 92 2005 163 167
4. G.D. Friedman, N. Oestreicher, J. Chan, C.P. Quesenberry Jr., N. Udaltsova, and L.A. Habel Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women Cancer Epidemiol Biomarkers Prev 15 2006 2102 2106
5. L.A. Garcia Rodriguez, and A. Gonzalez-Perez Use of antibiotics and risk of breast cancer Am J Epidemio 161 2005 616 619
6. J.A. Kaye, and H. Jick Antibiotics and the risk of breast cancer Epidemiology 16 2005 688 690
7. H.T. Sorensen, M.V. Skriver, S. Friis, J.K. McLaughlin, W.J. Blot, and J.A. Baron Use of antibiotics and risk of breast cancer: a population-based case-control study Br J Cancer 92 2005 594 596
8. R.R. Monson, S. Yen, and B. MacMahon Chronic mastitis and carcinoma of the breast Lancet 2 1976 224 226
9. A. Kilkkinen, H. Rissanen, T. Klaukka, E. Pukkala, M. Heliovaara, and P. Huovinen Antibiotic use predicts an increased risk of cancer Int J Cancer 123 2008 2152 2155
10. H. Tamim, J.F. Boivin, J. Hanley, M. Stang, and J.P. Collet Risk of breast cancer in association with exposure to two different groups of tricyclic antidepressants Pharmacoepidemiol Drug Saf 15 2006 689 697
11. W. Xu, H. Tamim, S. Shapiro, M.R. Stang, and J.P. Collet Use of antidepressants and risk of colorectal cancer: a nested case control study Lancet Oncol 7 2006 301 308
12. W. Downey Health databases in Saskatchewan B. Strom, Pharmacoepidemiology 3rd ed. 2000 John Wiley and Sons, Ltd. Chichester 325 345
13. C. Percy, V. Van Molten, and C. Muir International Classification of Diseases for Oncology (ICD-O) 2nd ed. 1990 World Health Organization Geneva
14. G. Mandell, R. Douglas, J. Bennett, and R. Dolin Douglas and Bennett's Principles and Practice of Infectious Diseases 4th ed. 2000 Churchill Livingstone Philadelphia
15. H. Tamim, A.A. Monfared, and J. LeLorier Application of lag-time into exposure definitions to control for protopathic bias Pharmacoepidemiol Drug Saf 16 2007 250 258
16. SAS Institute Inc. The SAS system for windows software, release 9.1: SAS Institute Inc: NC; 1999.
17. T. Anttila, P. Saikku, P. Koskela, A. Bloigu, J. Dillner, and I. Ikäheimo Serotypes of chlamydia trachomatis and risk for development of cervical squamous cell carcinoma JAMA 285 2001 47 51
18. L.A. Koutsky, K.K. Holmes, C.W. Critchlow, C.E. Stevens, J. Paavonen, and A.M. Beckmann A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection N Engl J Med 327 1992 1272 1278
19. J.J. Platz-Christensen, E. Sundstrom, and P.G. Larsson Bacterial vaginosis and cervical intraepithelial neoplasia Acta Obstet Gynecol Scand 73 1994 586 588
20. J.S. Smith, R. Herrero, C. Bosetti, N. Muñoz, F.X. Bosch, and J. Eluf-Neto International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer J Natl Cancer Inst 94 2002 1604 1613
21. M. Viikki, E. Pukkala, P. Nieminen, and M. Hakama Gynaecological infections as risk determinants of subsequent cervical neoplasia Acta Oncol 39 2000 71 75
22. T. Schlott, H. Eiffert, W. Bohne, J. Landgrebe, E. Brunner, and B. Spielbauer Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue Gynecol Oncol 98 2005 409 419